Figure 7

Evaluation of the predictive ability of the myeloid cell differentiation—related gene signature. (A, B) Time-dependent ROC curve of risk model at 1-, 3-, 5- year in TCGA and GEO cohorts. (C) The nomogram for predicting the overall survival of TCGA-LUAD patients. (D–F) Calibration curves for evaluating the compatibility between the predicted and actual outcomes at 1-, 3-, 5- year in TCGA cohort. (G–I) Calibration curves for evaluating the compatibility between the predicted and actual outcomes at 1-, 3-, 5- year in GEO cohort.